Hohl RJ - Search Results

1

RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthins.

Weissenrieder JS, Weissenkampen JD, Reed JL, Green MV, Zheng C, Neighbors JD, Liu DJ, Hohl RJ. Weissenrieder JS, et al. Among authors: hohl rj. Sci Rep. 2022 Jan 10;12(1):359. doi: 10.1038/s41598-021-04117-7. Sci Rep. 2022. PMID: 35013404 Free PMC article.

2

Schweinfurthins: Lipid Modulators with Promising Anticancer Activity.

Koubek EJ, Weissenrieder JS, Neighbors JD, Hohl RJ. Koubek EJ, et al. Among authors: hohl rj. Lipids. 2018 Aug;53(8):767-784. doi: 10.1002/lipd.12088. Epub 2018 Oct 17. Lipids. 2018. PMID: 30334267 Review.

3

Schweinfurthin induces ICD without ER stress and caspase activation.

Zhang R, Neighbors JD, Schell TD, Hohl RJ. Zhang R, et al. Among authors: hohl rj. Oncoimmunology. 2022 Aug 3;11(1):2104551. doi: 10.1080/2162402X.2022.2104551. eCollection 2022. Oncoimmunology. 2022. PMID: 35936984 Free PMC article.

4

Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.

Mente NR, Wiemer AJ, Neighbors JD, Beutler JA, Hohl RJ, Wiemer DF. Mente NR, et al. Among authors: hohl rj. Bioorg Med Chem Lett. 2007 Feb 15;17(4):911-5. doi: 10.1016/j.bmcl.2006.11.096. Epub 2006 Dec 12. Bioorg Med Chem Lett. 2007. PMID: 17236766

5

Synthesis and biological activity of a fluorescent schweinfurthin analogue.

Kuder CH, Neighbors JD, Hohl RJ, Wiemer DF. Kuder CH, et al. Among authors: hohl rj. Bioorg Med Chem. 2009 Jul 1;17(13):4718-23. doi: 10.1016/j.bmc.2009.04.071. Epub 2009 May 6. Bioorg Med Chem. 2009. PMID: 19464190 Free PMC article.

6

Fluorescent schweinfurthin B and F analogs with anti-proliferative activity.

Topczewski JJ, Kuder CH, Neighbors JD, Hohl RJ, Wiemer DF. Topczewski JJ, et al. Among authors: hohl rj. Bioorg Med Chem. 2010 Sep 15;18(18):6734-41. doi: 10.1016/j.bmc.2010.07.056. Epub 2010 Jul 29. Bioorg Med Chem. 2010. PMID: 20724169 Free PMC article.

7

3-Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines.

Kuder CH, Weivoda MM, Zhang Y, Zhu J, Neighbors JD, Wiemer DF, Hohl RJ. Kuder CH, et al. Among authors: hohl rj. Lipids. 2015 Dec;50(12):1195-207. doi: 10.1007/s11745-015-4083-z. Epub 2015 Oct 22. Lipids. 2015. PMID: 26494560 Free PMC article.

8

Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis.

Reilly JE, Neighbors JD, Hohl RJ. Reilly JE, et al. Among authors: hohl rj. Cancer Biol Ther. 2017 Nov 2;18(11):872-882. doi: 10.1080/15384047.2016.1219817. Epub 2016 Sep 13. Cancer Biol Ther. 2017. PMID: 27624889 Free PMC article. Clinical Trial.

9

Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.

Weissenrieder JS, Reilly JE, Neighbors JD, Hohl RJ. Weissenrieder JS, et al. Among authors: hohl rj. Prostate. 2019 Jan;79(1):21-30. doi: 10.1002/pros.23707. Epub 2018 Aug 14. Prostate. 2019. PMID: 30106164

10

Cancer and the Dopamine D₂ Receptor: A Pharmacological Perspective.

Weissenrieder JS, Neighbors JD, Mailman RB, Hohl RJ. Weissenrieder JS, et al. Among authors: hohl rj. J Pharmacol Exp Ther. 2019 Jul;370(1):111-126. doi: 10.1124/jpet.119.256818. Epub 2019 Apr 18. J Pharmacol Exp Ther. 2019. PMID: 31000578 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page